AbbVie Inc., Bausch Health Companies Inc., and Henry Schein, Inc. are dominating the Global Aesthetic Dermatology Market in 2021

The Global Aesthetic Dermatology Market is expected to grow with a CAGR of 10.2% in the forecast period of 2022 to 2029. The years considered for the study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-aesthetic-dermatology-market

The aesthetic dermatology market has witnessed increased strategic developments owing to favourable market scenario. 

The major players dealing in the aesthetic dermatology market are introducing strong range of products and adopting strategic initiative such as acquisition, agreement into the market. This helped companies to maximize the sales with enhanced product portfolio.

For instance-

  • In December 2021, AbbVie Inc. announced the acquisition of Soliton, Inc. The acquisition would help the company to increase its aesthetics portfolio of non-invasive body contouring treatments

AbbVie Inc. is the dominating player in the aesthetic dermatology market. The other key players existing in the market include Henry Schein, Inc., Merz Pharma, Cutera, Cynosure. Inc. (A Subsidiary of Hologic, Inc.), Candela Medical, Bausch Health Companies Inc., Evolus, Inc., Medytox, LUTRONIC, HUGEL, Inc., El. En. S.p.A., Hoahai, REVANCE THERAPEUTICS, Lumenis Be Ltd., Venus Concept, Alma Lasers, Fotona, Aesthetic Biomedical, ThermiGen, LLC., R2 TECHNOLOGIES, INC. (A Subsidiary of INNOVATE Corp.), Sensus Healthcare, Inc., Aesthetic Technology Limited, DELEO, Biotech Italia Srl, Medency, Aerolase Corp., Sciton, Image Derm, Inc., and PhotoMedex among others. 

AbbVie Inc.

AbbVie Inc. is headquartered in Illinois, U.S., and was founded in 2013. The company is engaged in providing services in key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health, and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. The company has business segments as immunology, hematology oncology, aesthetics and neuroscience in which the market focused segment is aesthetics. the company has product categories immunology, oncology, neuroscience, eye care, virology, and aesthetics in which market focused category is aesthetics. The company is engaged in continuous development of aesthetic products.

For instance,

  • In May 2020, AbbVie Inc. announced that it has completed the acquisition of Allergan which is a leading provider of aesthetic products in the market. The acquisition has helped the company to increase its product portfolio

The company has subsidiaries such as Pharmacyclics (U.S.), Stemcentrix, Inc. (U.S.), Allergan France (France), Life Cell (U.S.), and Repros Therapeutics (U.S.) among others. The company has wide presence across Asia-Pacific, Europe, North America, South America and Middle East and Africa.

Bausch Health Companies Inc.

Bausch Health Companies Inc. is headquartered in Quebec, Canada and was founded in 1959. The company develop, manufacture and market a range of products primarily in gastroenterology, neurology, dermatology and international pharmaceuticals. The company is dealing in business segments, that is, Bausch + Lomb, Salix, International Rx, ortho dermatologic and diversified products in which the market focused segment is ortho dermatologic. The company has product categories including gastrointestinal, dermatology products/aesthetic devices, generics, neurology and other, dentistry and consumer health in which the market focused category is dermatology products/aesthetic devices.

The company is engaged in the continuous development of aesthetic products.

For instance,

  • In October 2020, Bausch Health Companies Inc. announced that it has participated in Fall Clinical Dermatology Conference. This has helped the company to feature new efficacy and safety analysis of new dermatology products

The company has wide presence across North America, South America, Europe, Middle East and Africa, Asia-Pacific. The company also has various subsidiary companies such as Valent Canada Ltd (Canada), Valent Pharmaceuticals Russia LLC (Russia), Laboratories Valent Argentina SA (Argentina), Salix Pharmaceuticals (U.S.), and Bosch + Lomb (U.S.) among others.

Henry Schein, Inc.

Henry Schein, Inc. has its headquarters in New York, U.S. and was founded in 1932. The company is engaged in providing health care products and services primarily to office-based dental and medical practitioners. This company has product categories including medical surgical supplies, medical equipment, lab supplies and pharmaceutical supplies in which the market focused categories are medical equipment, pharmaceutical supplies.

The company is engaged in continuous development of aesthetics products.

The company has wide presence across North America, Europe, and Middle East and Africa.